Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value: $939M (99.2% shares, 0.8% debt)

Holdings (22)

INGN INOGEN INC 29.3%

Value $275M Shares 3,549,320 Share Price $77.56 * Est. Cost/Share $17.78 Unrealized @ Report Date +289.7%

ANAB ANAPTYSBIO INC 9.0%

Value $84.18M Shares 3,033,504 Share Price $27.75 * Est. Cost/Share $23.32 Unrealized @ Report Date 0.0%

— REATA PHARMACEUTICALS INC 8.1%

Value $76.28M Shares 3,367,763 Share Price $22.65 Est. Cost/Share $19.75 Unrealized @ Report Date —

IRTC IRHYTHM TECHNOLOGIES INC 8.1%

Value $76.12M Shares 2,024,448 Share Price $37.60 * Est. Cost/Share $26.94 Unrealized @ Report Date +27.7%

CRVS CORVUS PHARMACEUTICALS INC 7.1%

Value $66.96M Shares 3,224,046 Share Price $20.77 * Est. Cost/Share $14.33 Unrealized @ Report Date +9.3%

— RA PHARMACEUTICALS INC 4.6%

Value $43.25M Shares 2,031,562 Share Price $21.29 Est. Cost/Share $15.19 Unrealized @ Report Date —

— ACCELERON PHARMA INC 4.4%

Value $41.13M Shares 1,553,937 Share Price $26.47 Est. Cost/Share $27.65 Unrealized @ Report Date —

— FLEXION THERAPEUTICS INC 4.0%

Value $37.61M Shares 1,397,718 Share Price $26.91 Est. Cost/Share $16.32 Unrealized @ Report Date —

— MERUS N V 3.7%

Value $34.4M Shares 1,410,417 Share Price $24.39 Est. Cost/Share $7.99 Unrealized @ Report Date —

— SPECTRANETICS CORP 3.7%

Value $34.34M Shares 1,179,122 Share Price $29.13 Est. Cost/Share $18.19 Unrealized @ Report Date —

— OBSEVA SA 3.4%

Value $31.69M Shares 3,044,093 Share Price $10.41 Est. Cost/Share $10.41 Unrealized @ Report Date —

— NABRIVA THERAPEUTICS AG 3.0%

Value $27.92M Shares 2,326,544 Share Price $12.00 Est. Cost/Share $7.44 Unrealized @ Report Date —

— DERMIRA INC 2.7%

Value $25.52M Shares 748,240 Share Price $34.11 Est. Cost/Share $33.02 Unrealized @ Report Date —

KALV KALVISTA PHARMACEUTICALS INC 2.4%

Value $22.66M Shares 2,901,927 Share Price $7.81 * Est. Cost/Share $7.37 Unrealized @ Report Date +1.9%

— APOLLO ENDOSURGERY INC 1.9%

Value $18.24M Shares 1,456,972 Share Price $12.52 Est. Cost/Share $12.16 Unrealized @ Report Date —

AKBA AKEBIA THERAPEUTICS INC 1.2%

Value $11.71M Shares 1,272,247 Share Price $9.20 * Est. Cost/Share $9.76 Unrealized @ Report Date 0.0%

— INVUITY INC 1.1%

Value $10.48M Shares 1,318,448 Share Price $7.95 Est. Cost/Share $9.58 Unrealized @ Report Date —

— HTG MOLECULAR DIAGNOSTICS INC 0.9%

Value $8.859M Shares 1,280,185 Share Price $6.92 Est. Cost/Share $11.15 Unrealized @ Report Date —

— WRIGHT MED GROUP N V 0.8%

Value $7.072M Shares 4,622,032 Share Price $1.53 Est. Cost/Share $1.25 Unrealized @ Report Date —

CRSP CRISPR THERAPEUTICS AG 0.5%

Value $4.862M Shares 223,317 Share Price $21.77 * Est. Cost/Share $18.69 Unrealized @ Report Date +5.1%

XENE XENON PHARMACEUTICALS INC 0.1%

Value $510K Shares 127,563 Share Price $4.00 * Est. Cost/Share $14.68 Unrealized @ Report Date -46.5%

OPK OPKO HEALTH INC 0.0%

Value $2,000 Shares 259 Share Price $7.72 * Est. Cost/Share $9.96 Unrealized @ Report Date -15.4%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
INGN	INOGEN INC	3,549,320	$275M	29.3%	$77.56 *	$17.78	+289.7%	COM	45780L104
ANAB	ANAPTYSBIO INC	3,033,504	$84.18M	9.0%	$27.75 *	$23.32	0.0%	COM	032724106
—	REATA PHARMACEUTICALS INC	3,367,763	$76.28M	8.1%	$22.65	$19.75	—	CL A	75615P103
IRTC	IRHYTHM TECHNOLOGIES INC	2,024,448	$76.12M	8.1%	$37.60 *	$26.94	+27.7%	COM	450056106
CRVS	CORVUS PHARMACEUTICALS INC	3,224,046	$66.96M	7.1%	$20.77 *	$14.33	+9.3%	COM	221015100
—	RA PHARMACEUTICALS INC	2,031,562	$43.25M	4.6%	$21.29	$15.19	—	COM	74933V108
—	ACCELERON PHARMA INC	1,553,937	$41.13M	4.4%	$26.47	$27.65	—	COM	00434H108
—	FLEXION THERAPEUTICS INC	1,397,718	$37.61M	4.0%	$26.91	$16.32	—	COM	33938J106
—	MERUS N V	1,410,417	$34.4M	3.7%	$24.39	$7.99	—	COM	N5749R100
—	SPECTRANETICS CORP	1,179,122	$34.34M	3.7%	$29.13	$18.19	—	COM	84760C107
—	OBSEVA SA	3,044,093	$31.69M	3.4%	$10.41	$10.41	—	COM	H5861P103
—	NABRIVA THERAPEUTICS AG	2,326,544	$27.92M	3.0%	$12.00	$7.44	—	COM	62957M104
—	DERMIRA INC	748,240	$25.52M	2.7%	$34.11	$33.02	—	COM	24983L104
KALV	KALVISTA PHARMACEUTICALS INC	2,901,927	$22.66M	2.4%	$7.81 *	$7.37	+1.9%	COM	483497103
—	APOLLO ENDOSURGERY INC	1,456,972	$18.24M	1.9%	$12.52	$12.16	—	COM	03767D108
AKBA	AKEBIA THERAPEUTICS INC	1,272,247	$11.71M	1.2%	$9.20 *	$9.76	0.0%	COM	00972D105
—	INVUITY INC	1,318,448	$10.48M	1.1%	$7.95	$9.58	—	COM	46187J205
—	HTG MOLECULAR DIAGNOSTICS INC	1,280,185	$8.859M	0.9%	$6.92	$11.15	—	COM	40434H104
—	WRIGHT MED GROUP N V	4,622,032	$7.072M	0.8%	$1.53	$1.25	—	RIGHT 03/01/2019	N96617126
CRSP	CRISPR THERAPEUTICS AG	223,317	$4.862M	0.5%	$21.77 *	$18.69	+5.1%	NAMEN AKT	H17182108
XENE	XENON PHARMACEUTICALS INC	127,563	$510K	0.1%	$4.00 *	$14.68	-46.5%	COM	98420N105
OPK	OPKO HEALTH INC	259	$2,000	0.0%	$7.72 *	$9.96	-15.4%	COM	68375N103